1. Home
  2. GHRS vs WOLF Comparison

GHRS vs WOLF Comparison

Compare GHRS & WOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • WOLF
  • Stock Information
  • Founded
  • GHRS 2018
  • WOLF 1987
  • Country
  • GHRS Ireland
  • WOLF United States
  • Employees
  • GHRS N/A
  • WOLF N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • WOLF Semiconductors
  • Sector
  • GHRS Health Care
  • WOLF Technology
  • Exchange
  • GHRS Nasdaq
  • WOLF Nasdaq
  • Market Cap
  • GHRS 892.0M
  • WOLF 838.3M
  • IPO Year
  • GHRS 2021
  • WOLF 1993
  • Fundamental
  • Price
  • GHRS $14.38
  • WOLF $17.94
  • Analyst Decision
  • GHRS Strong Buy
  • WOLF Hold
  • Analyst Count
  • GHRS 9
  • WOLF 8
  • Target Price
  • GHRS $30.11
  • WOLF $9.86
  • AVG Volume (30 Days)
  • GHRS 407.8K
  • WOLF 2.1M
  • Earning Date
  • GHRS 11-06-2025
  • WOLF 10-29-2025
  • Dividend Yield
  • GHRS N/A
  • WOLF N/A
  • EPS Growth
  • GHRS N/A
  • WOLF N/A
  • EPS
  • GHRS N/A
  • WOLF N/A
  • Revenue
  • GHRS N/A
  • WOLF $759,700,000.00
  • Revenue This Year
  • GHRS N/A
  • WOLF $16.42
  • Revenue Next Year
  • GHRS N/A
  • WOLF N/A
  • P/E Ratio
  • GHRS N/A
  • WOLF N/A
  • Revenue Growth
  • GHRS N/A
  • WOLF N/A
  • 52 Week Low
  • GHRS $6.72
  • WOLF $8.05
  • 52 Week High
  • GHRS $20.50
  • WOLF $36.60
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 55.96
  • WOLF 41.28
  • Support Level
  • GHRS $13.71
  • WOLF $16.47
  • Resistance Level
  • GHRS $15.01
  • WOLF $18.95
  • Average True Range (ATR)
  • GHRS 0.98
  • WOLF 1.64
  • MACD
  • GHRS 0.04
  • WOLF -0.46
  • Stochastic Oscillator
  • GHRS 74.17
  • WOLF 28.71

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About WOLF Wolfspeed Inc.

Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.

Share on Social Networks: